AIM
FOMX

ARK Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

ARK Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-110,343
Closed -$367K – 222
2019
Q4 		$367K Sell
110,343
-85,817
-44% -$273K 0.01% 166
2019
Q3 		$596K Buy
196,160
+49,415
+34% +$139K 0.01% 136
2019
Q2 		$349K Buy
146,745
+29,378
+25% +$87.8K 0.01% 168
2019
Q1 		$440K Buy
117,367
+22,989
+24% +$86.1K 0.01% 146
2018
Q4 		$339K Sell
94,378
-5,523
-6% -$24K 0.01% 139
2018
Q3 		$572K Sell
99,901
-6,342
-6% -$36.3K 0.02% 133
2018
Q2 		$532K Buy
106,243
+15,980
+18% +$82.3K 0.02% 134
2018
Q1 		$463K Buy
90,263
+51,103
+130% +$308K 0.02% 144
2017
Q4 		$235K Buy
+39,160
New +$236K 0.02% 146

ARK Investment Management's FOMX Position: Q1 2020 in Review

ARK Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 110,343 shares — an estimated $367K sold.

ARK Investment Management first reported a position in FOMX in Q4 2017 and held it in 9 quarters. The position peaked at $596K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • ARK Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • ARK Investment Management sold 110,343 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $367K.
  • ARK Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2017 and held it in 9 quarters.
  • ARK Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $596K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on ARK Investment Management's 13F filing for Q1 2020, filed 14 May 2020.